| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/05/2005 | US20050096271 Fusion of polypeptides and immunoglobulin protein; immunotherapy ; antiallergens; antiarthritic agents; anticancer agents; antiinflammatory agents |
| 05/05/2005 | US20050096268 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 05/05/2005 | US20050096253 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 05/04/2005 | EP1528058A1 Polymorphic crystalline forms of celecoxib |
| 05/04/2005 | EP1527781A1 Antipruritic agent |
| 05/04/2005 | EP1527178A2 Novel class ii cytokine receptors and uses thereof |
| 05/04/2005 | EP1527084A2 Promoters exhibiting endothelial cell specificity and methods of using same |
| 05/04/2005 | EP1527075A1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 05/04/2005 | EP1527074A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/04/2005 | EP1527068A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 05/04/2005 | EP1527051A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 05/04/2005 | EP1527046A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 05/04/2005 | EP1526895A2 Methods for treating carbonic anhydrase mediated disorders |
| 05/04/2005 | EP1526869A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 05/04/2005 | EP1526867A2 Use of erythropoietin |
| 05/04/2005 | EP1526854A1 4-4(methylpiperazin-1-ylmethyl)-n- 4-methyl-3-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl -benzamide for treating mutated-ret kinase associated diseases |
| 05/04/2005 | EP1526852A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/04/2005 | EP1526851A2 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 05/04/2005 | EP1526847A2 Pharmaceutical dosage form comprising a sulfite compound |
| 05/04/2005 | EP1526846A2 Gelatin capsule exhibiting reduced cross-linking |
| 05/04/2005 | EP1526845A2 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 05/04/2005 | EP1526844A2 Pellicle-resistant gelatin capsule |
| 05/04/2005 | EP1401466B1 Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue |
| 05/04/2005 | EP1395582B1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/04/2005 | EP1362048B1 Triazolo compounds as mmp inhibitors |
| 05/04/2005 | EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2005 | EP1286679B1 Skin treatment preparation |
| 05/04/2005 | EP1259477B1 Aminoadamantane derivatives as therapeutic agents |
| 05/04/2005 | EP1240165B1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 05/04/2005 | EP1140001B1 Composition for treatment of burns |
| 05/04/2005 | EP1124810B1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/04/2005 | EP0973529B1 Essential oil composition |
| 05/04/2005 | EP0781340B1 Vaccine against group A Streptococcal infection |
| 05/04/2005 | CN1612893A VEGF peptides and their use for inhibiting angiogenesis |
| 05/04/2005 | CN1612869A Novel 1, 2, 4-thiadiazolium derivatives as melanocortin receptor modulators |
| 05/04/2005 | CN1612852A Lipoxin A4 analogs |
| 05/04/2005 | CN1612756A Composition and method for treatment of wounds |
| 05/04/2005 | CN1612751A Combination treatments for allergic disease comprising administering an anti-IgE antibody and antiallergic compound |
| 05/04/2005 | CN1612745A Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 05/04/2005 | CN1612742A Composition and method |
| 05/04/2005 | CN1612739A Method for treating or preventing inflammatory diseases |
| 05/04/2005 | CN1612734A Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 05/04/2005 | CN1612733A Benzimidazoles useful as protein kinase inhibitors |
| 05/04/2005 | CN1612731A Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases |
| 05/04/2005 | CN1612729A 2-aryl-propionic acid and medicine composition containing same |
| 05/04/2005 | CN1612723A Local compositions containing enzymes stabilized with inhibitors |
| 05/04/2005 | CN1611514A Egg containing mixed IgY directed against about four antigens resulting acne and production method for its yolk powder and said mixd IgY |
| 05/04/2005 | CN1611513A Process of high purity albumin production |
| 05/04/2005 | CN1611256A Pernio ointment for treating itch and pain |
| 05/04/2005 | CN1611244A Angelica dehurica skin-modifying powder |
| 05/04/2005 | CN1611213A Novel 13 uses of neoarsphenamine |
| 05/04/2005 | CN1611212A Anchoic acid emulsifiable paste and its preparing method |
| 05/04/2005 | CN1199946C Specific indole compound and its preparation and use in treating and preventing cancers |
| 05/04/2005 | CN1199674C Douching lotion for treating women's genital system disease |
| 05/04/2005 | CN1199670C Chinese medicine for treating leukodema |
| 05/04/2005 | CN1199668C Chinese-medicinal ointment for treating burn and scald and its preparing process |
| 05/04/2005 | CN1199667C Paste for curing burn and scald and its preparing method |
| 05/04/2005 | CN1199666C Powdered medicine for treating intractable ulcer |
| 05/04/2005 | CN1199660C Powdered medicnie 'shaotangsan' for treating burn and scald |
| 05/04/2005 | CN1199567C Hybrid matrix implants and explants |
| 05/03/2005 | US6888027 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| 05/03/2005 | US6887998 Process for 8-carboxamido-2,6-methano-3-benzazocines |
| 05/03/2005 | US6887987 DNA encoding the human serine protease T |
| 05/03/2005 | US6887903 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 05/03/2005 | US6887895 Aminolyzing; alcoholysis; comprises acid catalysts; for treatment of tumors or inhibition of fungi |
| 05/03/2005 | US6887892 Tricyclic derivatives of indole with antiangiogenic activity |
| 05/03/2005 | US6887883 Combating angiogenic activity in a human comprising administering to a chrysanthone compound |
| 05/03/2005 | US6887874 For producing an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal; therapy of cancer, rheumatoid arthritis |
| 05/03/2005 | US6887872 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 05/03/2005 | US6887680 Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays |
| 05/03/2005 | US6887670 For drug screening; solid phase synthesis; fusion proteins; genetic engineering |
| 05/03/2005 | US6887490 Use in the delivery of therapeutic agents to selected tissues and advantageously has the potential to repair/replace damaged tissue |
| 05/03/2005 | US6887462 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta (IFN-beata) |
| 05/03/2005 | US6887460 Cosmetic or pharmaceutical preparations which comprise enaminotriazines as light protection agents, and novel enaminotriazines |
| 05/03/2005 | US6887260 Method and apparatus for acne treatment |
| 05/03/2005 | CA2347950C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 05/03/2005 | CA2154652C Pharmaceutical and dermocosmetic compositions containing equine colostrum |
| 05/03/2005 | CA2147623C Novel p-selectin ligand protein |
| 05/03/2005 | CA2103189C Tetracyclines including non-antimicrobial chemically-modified tetracyclines inhibit excessive collagen crosslinking during diabetes |
| 04/28/2005 | WO2005037772A2 Novel ligand activating receptors rars used for human medicine and cosmetics |
| 04/28/2005 | WO2005036989A1 Health food containing hyaluronic acid and dermatan sulfate |
| 04/28/2005 | WO2004108139A8 Use of fused heterocyclic compounds as scce inhibitors for the treatment of skin conditions or cancer |
| 04/28/2005 | WO2004084905A3 Use of 5-ht2c receptor activity affecting compounds for treating idiopathic hyperhidrosis and associated conditions |
| 04/28/2005 | WO2003099201A3 Compositions and methods of use for a fibroblast growth factor |
| 04/28/2005 | WO2003044170A3 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 04/28/2005 | US20050090555 Compound for the treatment of metabolic disorders |
| 04/28/2005 | US20050090536 Substituted pyrrol-3-ylisoxazoles, e.g., N-benzyl-4-[4-(o-chlorophenyl)-5-isoxazolyl)pyrrole-2-carboxamide; treating diseases that are alleviated by a protein kinase inhibitor, particularly cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
| 04/28/2005 | US20050090524 Novel adamantane derivatives |
| 04/28/2005 | US20050090519 1-Alkyl-4-(3-substitutedphenyl)piperidines |
| 04/28/2005 | US20050090517 Pharmaceutical combinations of cox-2 inhibitors and opiates |
| 04/28/2005 | US20050090493 Useful as anti-cancer agents; exhibit apoptotic effect in a warm-blooded animal such as man; for example, 2-{4-[3-(N,N-Dimethyl)amino-2-hydroxy-propoxy]anilino}-4-(2,4-difluoro-(N-cyanomethyl)anilino)pyrimidine |
| 04/28/2005 | US20050090491 2'-Methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/28/2005 | US20050090490 3-Substituted-4-pyrimidone derivatives |
| 04/28/2005 | US20050090489 An alpha hydroxy acid or a retinoid as a bacterial fermentation product of a novel Streptomyces strain; topical antiwrinkle agents |
| 04/28/2005 | US20050090487 Cardiovascular disorders; antiinflammatory agents |
| 04/28/2005 | US20050090481 having improved stability and side effect reduction; tissue-targeted therapy |
| 04/28/2005 | US20050090471 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 04/28/2005 | US20050089970 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 04/28/2005 | US20050089933 Compositions and methods for surrogate antibody modulation of an immune response and transport |